About this trial
This project aims at unravelling mechanisms by which exposure to air pollution (in particular Ultrafine Particulate (UFP, PM0.1), and micro nano plastic's) interferes with the normal foetus development, with a short-term causal effect in higher likeliness of preterm delivery which, in consequence, precondition a higher likeliness to suffer non-communicable diseases (NCD) later in the life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Agreement to sign the informed consent;
Non-smoking mothers and no exposure to environmental (second-hand) smoke (smoking influences UFP measurements);
≥18 years old (mothers have to place sensors, mothers with childhood pregnancies may live at their parental home);
Not expecting to terminate the pregnancy (no measurements of the child);
Disqualifiers
First visit after 11 weeks of gestation (to ensure 2-week monitoring in the first trimester);
Pregnancy complications that limit exposure measurements in urine (because it may cause polyuria, for example, gestational diabetes);
Known kidney disease (might influence exposure measurements in urine);
Multiple pregnancy (twin or more pregnancies may have a higher risk for complications or preterm birth, no measurements in the last trimester).
Trial population
Pregnant mothers will be recruited at the first antenatal visit (around eight weeks of gestation).
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
PreTerm Birth
Small for Gestational Age
Low Birth Weigth
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Instituto de Investigacion Sanitaria La Fe
Lead sponsor
Hasselt University
Collaborator
Aristotle University Of Thessaloniki
Collaborator